Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer

NCT00050167 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

603

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Docetaxel
DRUG: Capecitabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]